Skip to content

Clinical trials

Terminated Phase 3 Diabetes Mellitus, Type 2 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Status: Terminated Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20039
20049
200510
200612
200712
20082
20098
20104
20113
20129
20135
20143
20151
20174
20189
20192
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated108

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Merck Sharp & Dohme LLC13
Takeda13
Sanofi12
Novo Nordisk A/S11
Phenomix4
Forest Laboratories3
Lexicon Pharmaceuticals3
Mannkind Corporation3
Intarcia Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2108
Diabetes Mellitus34
Dyslipidemias8
Glucose Metabolism Disorders8
Obesity8
Diabetes Mellitus, Type 17
Diabetes Mellitus, Lipoatrophic6
Cardiovascular Diseases5
Asthma3
Heart Failure3

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.